Drug intelligence / Profile preview

Ultrapure Biotech Sodium Chondroitin

Development stage
Preclinical
Lead developer
Altergon Italia
Administration
Intraarticular, Intraocular, Intravesical
01

Overview

Ultrapure Biotech Sodium Chondroitin is a patented, non-sulphated biotechnological glycosaminoglycan developed by Altergon Italia for injectable pharmaceutical applications. Produced through a proprietary fermentation and purification process at a dedicated biotechnology facility in Italy, this molecule is designed as a high-purity raw material for use in orthopedics, ophthalmology, and urology. In the treatment of osteoarthritis, it is notably utilized in combination with hyaluronic acid for intra-articular injections, where it serves as a technological excipient that regulates viscosity and enhances the therapeutic properties of the formulation. Its biotechnological origin ensures a high degree of purity and consistency compared to traditional animal-derived chondroitin sources.

Other names
Sodium ChondroitinBiotech Sodium ChondroitinNon-sulphated Biotech Sodium Chondroitin
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Ultrapure Biotech Sodium Chondroitin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultrapure Biotech Sodium Chondroitin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call